Veracity Capital’s Gilead Sciences GILD Stock Holding History

Veracity Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.11M	Sell	7,473 -311	-4%	-$43.6K	0.3%	59
2026 Q2	$983K	Buy	7,784 +711	+10%	+$93.7K	0.27%	76
2026 Q1	$986K	Sell	7,073 -376	-5%	-$52.7K	0.35%	56
2025 Q4	$914K	Sell	7,449 -22	-0.3%	-$2.67K	0.27%	74
2025 Q3	$829K	Sell	7,471 -126	-2%	-$14.3K	0.26%	74
2025 Q2	$842K	Sell	7,597 -604	-7%	-$64.3K	0.29%	75
2025 Q1	$919K	Sell	8,201 -532	-6%	-$54.9K	0.36%	59
2024 Q4	$807K	Buy	8,733 +3,213	+58%	+$289K	0.29%	78
2024 Q3	$463K	Buy	+5,520	New	+$421K	0.18%	123
2021 Q3	–	Sell	-7,373	Closed	-$508K	–	265
2021 Q2	$508K	Buy	+7,373	New	+$492K	0.12%	147
2020 Q3	–	Sell	-3,333	Closed	-$256K	–	224
2020 Q2	$256K	Buy	3,333 +2,148	+181%	+$165K	0.15%	153
2020 Q1	$89K	Buy	+1,185	New	+$81.9K	0.03%	213

Other funds holding GILD

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Veracity Capital's GILD Position: Q3 2026 in Review

Veracity Capital reduced its Gilead Sciences (GILD) stake by 4% in Q3 2026, selling an estimated $43.6K and leaving 7,473 shares worth $1.11M. The position accounts for 0.3% of the portfolio, ranked #59.

Veracity Capital first reported a position in GILD in Q1 2020 and has held it in 12 quarters since. 1,478 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

Veracity Capital held 7,473 shares of Gilead Sciences worth $1.11M as of Q3 2026.
Veracity Capital sold 311 Gilead Sciences shares in Q3 2026, an estimated $43.6K.
Gilead Sciences made up 0.3% of Veracity Capital's portfolio in Q3 2026, its #59 holding.
Veracity Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 12 quarters since.
1,478 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.